Dental Health

  One of the top dental implant manufacturers worldwide,  Straumann Group  expands in China building its first producing, education, and innovation center. Shanghai, 26 March 2021 – The Straumann Group, an international front-runner in implant and esthetic dental medicine, signed an investment contract with the Shanghai Xin Zhuang Industrial Park (SHXIP) to launch its foremost Campus in China encompassing manufacturing, teaching, and innovation center at one site. With financing of up to 1.2 billion Chinese yuan by 2029, the China Campus will offer a variety of educational curricula as well as products from the Group’s implant and orthodontics selection for China, supplying to the quickly mounting demands of Chinese dentists and patients for dental solutions. “China has to turn out to be one of the pioneers and trailblazers of dental care and innovation globally. We are thrilled about bolstering our presence to meet up the fast-increasing challenges of dentists and patients for dental

  Head and neck cancer  – new research eases back the development of tumors. A group lead by UCLA School of Dentistry is getting closer to finding a more efficient treatment that could treat head and neck cancer. According to the study by aiming a weakness in the  cellular progression  of cancer replication, they could alter its reaction to immunotherapy. The forecast for head and neck cancer is bad, with a high five-year mortality rate. They concentrated on the enzyme called KDM4A. The duplication and propagation of cancer cells is associated with an over-expression of the enzyme. Fight infection By eliminating the enzyme in a few mice, the scientists observed a considerable decline in the spreading of cancer to the lymph nodes. Which in turn could be a sign of metastasis of cancer in the body. The removal of the enzyme also led to stimulation of immunity in the form of  T cells and aided to increase natural cancer resistance. Additionally, they then launched a PD-1 blockade, which he